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Abstract
Background: Klebsiella pneumoniae is a bacterial pathogen that has developed resistance to multiple antibiotics
and is a major cause of nosocomial infections worldwide. Carbapenemase-producing Klebsiella pneumoniae have
been isolated in many hospitals in Venezuela, but they have not been well-studied. The aim of this study was to
characterize carbapenem-resistant Klebsiella pneumoniae isolates from the pediatric service of a hospital located in
Anzoategui State, in the eastern part of Venezuela.
Methods: Nineteen Klebsiella pneumoniae strains isolated in the hospital from April to July 2014 were evaluated
phenotypically and molecularly for the presence of carbapenemases blaKPC, blaIMP and blaVIM. Molecular
epidemiology was performed with Repetitive Extragenic Palindromic-PCR (REP-PCR) and Multilocus Sequence
Typing (MLST). They were also studied for phenotypic and molecular resistance to a quaternary ammonium
compound (QAC) disinfectant.
Results: All 19 isolates contained both blaVIM-2 and blaKPC-2 genes, and the blaKPC-2 gene was associated with
Tn4401b. All isolates were phenotypically sensitive to QACs and contained qacΔE and addA2 genes typical of class
1 integrons. Analysis by REP-PCR and MLST showed that all isolates had identical profiles characteristic of sequence
type ST833.
Conclusion: All 19 strains are blaVIM-2 and blaKPC-2−producing ST833 K. pneumoniae sensitive to QACs. This analysis
may help to understand the routes of dissemination and confirms that QAC disinfectants can be used to help
control their spread.
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Background
The emergence of plasmid-mediated carbapenem hydro-
lyzing β-lactamases and their spread amongst Gram-
negative bacteria, especially Klebsiella pneumoniae, has
become a serious threat for hospitalized patients world-
wide. The two principal types of acquired carbapene-
mases are the molecular class B metallo-β-lactamases
(MBLs) and the molecular class A K. pneumoniae
carbapenemases (KPCs), both of which have been de-
tected in many countries [1–4]. The blaVIM gene en-
codes a transferable carbapenemase and is generally
found within class 1 integrons. Although originally iden-
tified in Pseudomonas aeruginosa, VIM enzymes are
now endemic within Enterobacteriaceae [5, 6]. The
blaKPC genes are usually located within Tn4401 [7], a
Tn3-based transposon harbored on plasmids or in the
chromosome. In recent years carbapenem-resistant K.
pneumoniae has become a frequent cause of nosocomial
infections in several hospitals in different Venezuelan
cities [8], but the epidemiology, molecular epidemiology,
clinical impact and carbapenemase genes of Venezuelan
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carbapenemase-producing K. pneumoniae have not been
described. In this study we characterize 19 carbapenemase-
producing K. pneumoniae isolates associated with nosoco-
mial infections centered in the pediatric service of a large
Venezuelan tertiary-care public hospital. All 19 isolates
contained both blaVIM-2 and blaKPC-2 genes, were pheno-
typically sensitive to QACs and contained qacΔE and
addA2 genes typical of class 1 integrons. Analysis by REP-
PCR and MLST showed that all isolates had identical pro-
files characteristic of sequence type ST833.
Methods
Hospital setting
The “Rafael Tobías Guevara” Pediatrics Department is
part of the “Dr. Luis Razetti” Hospital, a large tertiary-care
public hospital with 502 beds, located in Anzoátegui State,
in the eastern part of Venezuela. The “Rafael Tobías
Guevara” Pediatrics Department has 73 beds in the neo-
natal unit, 3 delivery rooms, 28 beds in the neonatal inter-
mediate care unit and 12 beds in the neonatal intensive
care unit. In 2014 nearly 26,000 women gave birth in this
hospital, 30 % of whom were adolescents.
Study population
The study was conducted from April to July 2014 and
included all carbapenem-resistant Klebsiella pneumoniae
strains isolated from pediatric patients hospitalized in
the “Rafael Tobías Guevara” Pediatrics Department dur-
ing this period. If there were more than one isolate from
a patient, only the first was included in the study. Infor-
mation on the source of the clinical specimen, the pa-
tient’s age, gender and hospital location was obtained
from specimen records in the bacteriology laboratory
and made irreversibly anonymous. The Bioethics Com-
mission of the Instituto Venezolano de Investigaciones
Científicas determined that the study did not require its
approval.
Bacterial strains and antibiotic susceptibility testing
The study included 19 Klebsiella pneumoniae strains iso-
lated from April to July 2014 in the bacteriology labora-
tory of the “Rafael Tobías Guevara” Pediatrics
Department. They all showed intermediate or full resist-
ance to carbapenems according to the Clinical and La-
boratory Standards Institute (CLSI) 2014 cutoff points [9].
The broader antimicrobial susceptibility profile of the Klebsi-
ella pneumoniae strains was determined by the broth dilution
method according to the CLSI guidelines for the following
antibiotics: amikacin, tetracycline, chloramphenicol, amoxicil-
lin/clavulanic acid, ampicillin, ampicillin/sulbactam, cefalotin,
cefoxitin, ceftazidime, cefepime, piperacillin, piperacillin/tazo-
bactam, aztreonam, cefoperazone/sulbactam, imipenem, mer-
openem, ciprofloxacin, and trimethoprim/sulfamethoxazole.
Carbapenemase activity in all 19 isolates was confirmed by
the Hodge test [9]. The disk diffusion assay with ertape-
nem and 3-aminophenyl boronic acid (400 μg) was used
to confirm the presence of KPC-type β-lactamases [10],
and with ertapenem and EDTA to confirm the presence of
metallo- β-lactamases in all 19 isolates.
Detection of genes encoding β-lactamases and their genetic
environment, integron cassettes and efflux pumps
Bacterial strains were grown on MacConkey agar and in-
cubated overnight at 37 °C. One colony was resuspended
in 100 μl of sterile distilled water and the bacteria were
lysed by heating at 100 °C for 10 min. Cellular debris
was removed by centrifugation at 13,000 g for 10 min
and the supernatant was used as template DNA for PCR
amplifications [11].
The carbapenemase genes blaKPC [12] blaIMP and blaVIM
[13] were amplified by PCR using the primers listed in
Additional file 1: Table S1. The genetic environment of the
blaKPC genes was determined by PCR using previously de-
scribed primers [14] specific for the Tn4401 transposon
(Additional file 1: Table S1). To detect the qacΔE gene en-
coding a putative efflux pump often found in class 1 inte-
grons [15] as well as other integron cassettes [16], PCR was
performed using primers specific for the 5′ and 3′ con-
served integrons segments (Additional file 1: Table S1).
PCR was also used for to detect putative efflux pumps
qacA, qacB [15] and qacC genes [17] (Additional file 1:
Table S1). The positive controls for the PCR reactions were
characterized by phenotypic testing and PCR followed by
sequencing of the relevant genes: a KPC-producing K.
pneumoniae strain carrying a blaKPC gene; a IMP-
producing P. aeruginosa strain carrying a blaIMP gene; a P.
aeruginosa strain carrying a blaVIM gene; and 4 isolates of
A. baumannii resistant to QACs disinfectans carrying
qacA, qacB, qacC and qacΔE genes, respectively.
After PCR amplification, amplified fragments from the 19
clinical isolates were purified with Qiaquick PCR Spin col-
umns (Qiagen) and sequenced in both forward and reverse
directions (Macrogen, Korea) with the same primers used
for PCR amplification. The sequences were compared with
the National Center for Biotechnology Information (NCBI)
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) and Lahey data-
bases (http://www.lahey.org/Studies/).
Disinfectant susceptibility test in Klebsiella pneumoniae
isolates
Susceptibility to Quaternary Ammonium Compounds
(QACs) was determined using the quantitative sus-
pension test for bactericidal activity, according to the
protocol of Kawamura-Sato [18, 19]. The test was
performed with the commercial disinfectant most
commonly used in Venezuelan hospitals [20], which
contains 10 % lauryl dimethyl benzyl ammonium
bromide as the active QAC agent.
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Molecular genotyping
The genetic relationships amongst the 19 carbapenem-
resistance isolates were determined by Repetitive Element
Palindromic-PCR (REP-PCR) and Multi-Locus Sequence
Typing (MLST). REP-PCR was performed using previ-
ously described primers REP1 and REP2 [21] (Additional
file 1: Table S1). MLST was performed using the method-
ology described by Diancourt et al. [22] (Additional file 1:
Table S1). After PCR amplification, the fragments were se-
quenced with the amplification primers in the forward
and reverse directions by Macrogen, Korea. Allele num-
bers and sequence types (STs) were assigned by the Klebsi-
ella pneumoniae MLST web site (http://bigsdb.pasteur.fr/
klebsiella/klebsiella.html).
Plasmid analysis
Plasmid DNA was extracted by the Kieser extraction
method [23] and analyzed by gel electrophoresis in 0.7 %
agarose.
Results
Clinical and epidemiological characteristics
We analyzed 19 carbapenem-resistant K. pneumoniae
strains isolated from clinical specimens of an equal num-
ber of patients in the “Rafael Tobías Guevara” Pediatrics
Department located in the “Dr. Luis Razetti” Teaching
Hospital. The patients’ demographic and clinical charac-
teristics are summarized in Table 1. All infections were
health care associated. Fourteen patients (n = 14/19,
73.7 %) were newborns and 12 (n = 12/19, 63.1 %) were
male. The most common infection sites were blood-
stream (n = 15/19, 79 %) and bronchial secretions (n = 2/
19, 10.5 %) (Table 1).
Antibiotic susceptibility testing of K. pneumoniae isolates
All 19 isolates were resistant to trimethoprim-sulfamethoxazole,
imipenem and meropenem, but testing for resistance to
other antibiotics revealed seven resistance profiles. Profiles
2 and 5 were the most common with four isolates each,
followed by profiles 1 and 4 with three isolates each
(Table 2). The isolates in profile 7, the most resistant, were
not sensitive to any of antibiotics tested, while profile 2
isolates were the most sensitive, showing resistance only
to ciprofloxacin (Table 2). The percentages of isolates re-
sistant to other antibiotics were: amikacin, 63.2 %; cipro-
floxacin, 94.7 %; tetracycline, 84.2 %; chloramphenicol,
42.1 %; and tigecycline 15.8 %.
Detection of genes encoding β–lactamases
Using PCR, both the blaKPC-2 and blaVIM-2 genes were
detected in 100 % (n = 19/19) of the isolates, while the
blaIMP gene could not be amplified from any isolate.
Genetic environment of blaKPC gene
The blaKPC gene is generally associated with a Tn3-based
transposon, Tn4401, composed of a transposase gene, a
resolvase gene, the blaKPC gene and two insertion se-
quences (ISKpn6 and ISKpn7) [7]. Six isoforms of Tn4401
have been identified which differ by various deletions up-
stream of the blaKPC gene [24, 25]. Amplification of the re-
gions flanking the blaKPC-2 genes with Tn4401 specific
primers [14] produced a 703-bp PCR fragment from all 19
isolates, consistent with the Tn4401 variant “b” [14] (Fig. 1).
The ISKpn6 and tnpA genes were also amplified separately
from all 19 isolates, but the inverted repeat sequences of
Tn4401 could not be amplified with primers specific for
this region [7, 14, 26] (Additional file 1: Table S1).
Detection of genes located in class 1 integrons
Amplification and sequencing with primers specific for
class 1 integrons detected qacΔE and addA2 genes in all
19 isolates. The addA2 gene encodes an aminoglycoside
adenyltransferase that confers streptomycin resistance,
while qacΔE gene encodes a truncated Quaternary
Ammonium Compounds resistance protein.
Disinfectant susceptibility and molecular detection of the
qacA, qacB, and qacC genes
All 19 isolates were susceptible to a disinfectant containing
QAC agent lauryl dimethyl benzyl ammonium bromide.
Table 1 Clinical characteristics of patients infected by
carbapenem-resistant K. pneumoniae isolates from a Venezuelan
Hospital
No. (%) of isolates
Characteristic Total no.
Gender
Female 7 (36.9 %)
Male 12 (63.1 %)
Age
Newborn (0–6 days) 14 (73.7 %)
Lower infant (1–12 months) 2 (10.5 %)
Higher infant (1–2 years) 2 (10.5 %)
School (5–10 years) 1 (5.3 %)
Infection site
Bloodstream 15 (79 %)
Bronchial secretion 2 (10.4 %)
Catheter 1 (5.3 %)
Lesion secretion 1 (5.3 %)
Hospitalization área
Neonatal 12 (63.2 %)
Internal medicine 2 (10.5 %)
Intensive care 2 (10.5 %)
Surgery 3 (15.8 %)
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The qacA, qacB and qacC genes, implicated in resistance
to this type of disinfectants, could not be amplified from
any of the isolates.
Molecular genotyping
The REP-PCR technique produced very similar patterns
from all 19K. pneumoniae isolates. PCR amplification and
sequencing of the seven genes [22] used for MLST pro-
duced identical profiles from all 19 strains. Comparison
with the Klebsiella pneumoniae MLST website (http://
bigsdb.pasteur.fr/klebsiella/klebsiella.html) revealed that
this MLST profile is characteristic of sequence type,
ST833 (100 %, n = 19/19) (Fig. 1).
Plasmid analysis
Plasmid DNA was isolated from all 19 isolates, and the
plasmid profiles are shown in Fig. 2. It appears that there
are some similarly sized plasmids that are present in
almost all of the 19 isolates. These shared plasmids could
carry the located blaKPC-2, blaVIM-2, addA2 and qacΔE
genes, which have been commonly found in class 1 inte-
grons within transposons carried on plasmids [27–30].
Discussion
We report 19 carbapenem reistant K. pneumoniae
strains isolated from the pediatrics service of a hospital
in Venezuela that co-harbor both blaKPC and blaVIM
genes. All 19 strains appear to have identical Rep-PCR
profiles, and by MLST all appear to belong to ST833,
suggesting that this resistant strain has become endemic
in the pediatric service, especially in the neonatal units
of this hospital, where 12 of the strains were isolated.
The limited patient information available and irreversibly
anonymous nature of the strains did not permit retro-
spective analysis of the patients to exclude the possibility
that some represented colonization or transient carrier
Table 2 Antibiotic susceptibility profiles of carbapenem-resistant K. pneumoniae isolates from a Venezuelan Hospital
Profile:Isolates CM AK CIP TE TYG % of isolates
belonging profile
1: ANZ2, ANZ4, ANZ6 S S R S S 15.8
2: ANZ8, ANZ11, ANZ12, ANZ13 S S R R S 21.0
3: ANZ10 S R S R S 5.3
4: ANZ1, ANZ3, ANZ19 S R R R S 15.8
5: ANZ5, ANZ7, ANZ9, ANZ14 R R R R S 21.0
6: ANZ16 R R R R - 5.3
7: ANZ17, ANZ18, ANZ21 R R R R R 15.8
All strains were resistant to imipenem, meropenem, and trimethoprim-sulfamethoxazole
CM chloramphenicol, AK amikacin, CIP Ciprofloxacin, TE tetracycline, TGC tigecycline, (−) no data
Fig. 1 REP-PCR profiles of 19 isolates of blaVIM-2 and blaKPC-2-coharboring K. pneumoniae from a Public Venezuelan Hospital. Bands were visualized with
ethidium bromide staining on a 1.0 % TBE agarose gel. M: Molecular Weight Marker 100 bp ladder (New England Biolabs®), line 1: ANZ1, line 2: ANZ2,
line 3: ANZ3, line 4: ANZ4, line 5: ANZ5, line 6: ANZ6, line 7: ANZ7, line 8: ANZ8, line 9: ANZ9, line 10: ANZ10, line 11: ANZ11, line 12: ANZ12, line 13:
ANZ13, line 14: ANZ14, line 16: ANZ16, line 17: ANZ17, line 18: ANZ18, line 19: ANZ19, line 21: ANZ21. The table to the right illustrates results from the
blaKPC sequence analysis, MLST and sequence analysis of the nonconserved region of the Tn4401 element
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states with KPC-producing K. pneumoniae. This seems
unlikely, as 15 of the 19 strains were isolated from blood
cultures, suggesting they were associated with severe in-
fections. Cross contamination also seems unlikely as the
isolates showed seven different profiles of resistance to
other antibiotics.
There are no official data available about epidemio-
logical monitoring of bacteria causing nosocomial infec-
tions in Venezuelan hospitals. The only surveillance
program that provides data about antimicrobial resist-
ance in Venezuela is PROVENRA (http://provenra.clou-
dapp.net/), a private initiative with information on
antibiotic resistance from 1998 to 2012. The information
is collected from microbiology laboratories in 46 hospi-
tals nationwide, but does not include the “Dr. Luis
Razetti” hospital studied in the present report. Accord-
ing to data reported for 2012 on the PROVENRA web-
page, 72 % of K. pneumoniae isolated in neonatology
services were resistant to ertapenem and 65 % were re-
sistant to meropenem and imipenem (http://provenra.-
cloudapp.net/). This high prevalence of resistance was
confirmed in our study.
Other studies have described carbapenem resistance in
Venezuela. Fernández-Canigia and Dowziki in 2012 [31]
presented data from the Latin American region on
Gram-negative isolates used in the Tigecycline Evalu-
ation and Surveillance Trial (T.E.S.T.). They describe de-
creasing susceptibility to carbapenems among ESBL
producing K. pneumoniae in the Latin America coun-
tries studied, but found that 90.3 % of Venezuelan
strains were sensitive to meropenem. Jones et al. [32]
reported the results of a resistance surveillance program
monitoring antimicrobial susceptibility patterns in Latin
America in which only 15 % of Klebsiella isolates were
carbapenem-resistant. Finally, Kazmierczak et al. [33]
analyzed Gram-negative pathogens collected from 40
countries, including Venezuela, as part of a global
surveillance study in 2012–2014. Carbapenem non-
susceptible Enterobacteriaceae were characterized for
bla genes encoding MBLs and serine β-lactamases vari-
ants with PCR and sequencing. In the strains from
Venezuela there was one isolate of K. pneumoniae con-
taining NDM-1 and one isolate of P. aeruginosa carrying
VIM-2 [33].
The KPC-2 allele, one of 21 variants of the blaKPC gene,
was found in all our 19K. pneumoniae isolates and is one
of the most extensively distributed worldwide [34], includ-
ing in the South American countries of Colombia [35, 36]
Brazil [37–40] Argentina [41, 42]. In Venezuela [43, 44], a
KPC-2-producing K. oxytoca was isolated from a pediatric
patient in the state of Mérida [44], but to our knowledge,
KPC genes have not been previously reported in Venezue-
lan K. pneumoniae isolates.
In addition to the KPC-2 gene, all of our 19 isolates
also carried the VIM-2-carbapenemase. The blaVIM gene
is extensively distributed worldwide, with VIM-2 the
most widespread variant [45]. Endemicity of VIM en-
zymes has been reported in Greece, Taiwan, and Japan
[46, 47], although outbreaks and single strains of VIM
producers have been reported in many other countries
including the Latin American countries of México,
Argentina, Colombia and Venezuela [45]. In Venezuela
the blaVIM gene was previously found in clinical isolates
of Pseudomonas aeruginosa [48, 49], and Marcano et al.
[50] reported VIM-producing carbapenem-resistant K.
pneumoniae isolated from the urine of a 7-year-old girl
hospitalized at the “Hospital de Niños J. M. de los Ríos”
in Caracas, Venezuela.
Strains carrying both blaKPC and blaVIM carbapenemases
have been previously reported in Greece [1, 51–54]
Colombia [55], Germany [56], Italy [6], and Spain [57]. In
Venezuela the two carbapenemases have only been
Fig. 2 Plasmidic DNA profile of 19 isolates from a Public Venezuelan Hospital. Bands were visualized with ethidium bromide staining on a 0.7 % TBE
agarose gel. Line 1: 100 bp ladder (New England Biolabs®), line 2: Escherichia coli XL1-Blue (negative control), line 3: ANZ1, line 4: ANZ2, line 5: ANZ3,
line 6: ANZ4, line 7: ANZ5, line 8: ANZ6, line 9: ANZ7, line 10: ANZ8, line 11: ANZ9, line 12: ANZ10, line 13: 100 bp ladder (New England Biolabs®), line
14: Escherichia coli XL1-Blue (negative control), line 15: ANZ11, line 16: ANZ12, line 17: ANZ13, line 18: ANZ14, line 19: ANZ16, line 20: ANZ17, line 21:
ANZ18, line 22: ANZ19, line 23: ANZ21
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reported together in a multiply resistant strain of Entero-
bacter cloacae [58] isolated from the urine of a 83-year-
old patient in a hospital in the city of Cumaná, which is
only about 90 miles from hospital we studied. It might be
interesting to know whether both the E. cloacae and K.
pneumoniae isolates could be carrying these carbapene-
mase genes within the same transferable genetic context.
Class 1 integrons are the most common integron type
present in clinical isolates of the Enterobacteriaceae, and
are increasingly detected in isolates of K. pneumoniae.
The gene cassettes most frequently identified within
class 1 integrons in Enterobacteriaceae are those encod-
ing resistance to streptomycin (aadA) and trimethoprim
(dfrA) [59, 60]. By PCR we found that 19 K. pneumoniae
strains contained the addA2 gene within the 5′CS-3′CS
region of the integron. We did not look for the presence
of the dfrA gene, but all 19 strains were resistant to
trimethoprim-sulfamethoxazole. The qacΔE gene, which
has also been associated with class 1 integrons [61] was
amplified from all 19 isolates.
KPC genes are often found within a transposon-
associated element, Tn4401 [7]. Tn4401 possesses genes
encoding a transposase (tnpA) and a resolvase (tnpR),
and has been characterized as an active transposon that
is able to mobilize the blaKPC genes at high frequency
without target specificity [7, 25]. In all 19 strains in this
study the blaKPC-2 genes appeared to be within a Tn3-
based structure consistent with the Tn4401 isoform ‘b’
[62], which has been observed in Greece [63], Colombia
[14], Brazil [64] and the USA. Similar to the report by
Pereira et al. [64] the inverted repeat sequences of the
flanking regions were not amplified in our isolates, sug-
gesting that their insertion sites may be different from
those of K. pneumoniae YC described by Naas et al. [7].
The KPC and VIM genes are generally found on plas-
mids [65], and the plasmids profiles from all 19 strains
contained similar bands, suggesting that the integron
containing the carbapenemase genes could be present
within a transposable element on a common plasmid,
but further studies are needed to confirm this possibility.
All 19 isolates evaluated in this study demonstrated
similar patterns with REP-PCR analysis, and by MLST
all belonged to ST833, a genotype that has only been re-
ported in Israel [28] and Trieste, Italy [29]. Interestingly,
the ST833 K. pneumoniae strain isolated in the Trieste
Pediatric Hospital was from a blood culture of a 3-year-
old patient transferred from a Venezuelan hospital to
undergo marrow transplantation [29].
We have not found any previous studies describing
MLST characterization of K. pneumoniae strains isolated
in Venezuela, but we have used MLST to analyze the
strains of KPC-producing K. pneumoniae in a few other
hospitals in the country (manuscripts submitted). Al-
though the other hospitals always contained a variety of
sequence types, we found isolates belonging to ST833 in
hospitals in two other Venezuelan states–Zulia and the
Capital District. These are in the west and center of the
country, respectively, and distant from hospital studied
in the current report, which is located in the eastern
state of Anzoátegui. From our albeit limited sampling, it
appears that the carbapenem resistant K. pneumoniae
ST833 strain could be extensively distributed throughout
the country. Perhaps a Venezuelan patient acquired the
ST833 strain as an infection or colonization while hospi-
talized in Israel and then returned to Venezuela, where
it subsequently disseminated throughout the country
with the movements of patients and health care staff.
ST833 is part of the 258 clonal complex, and the
ST833 allelic profile (3-3-1-1-1-1-12) differs from
ST258 only in the tonB allele. The clonal complex
CC258 is the dominant and most successful KPC pro-
ducing strains as has spread widely and rapidly across
the world [30, 66], although the reasons for its appar-
ent advantage have yet to be completely explained fa-
cilitated by its production of proteins involved in cell
motility, secretion and DNA repair and modification
[67–69].
Disinfectants containing QACs are commonly used in
Venezuelan hospitals, and therefore the presence of
QAC resistance would complicate efforts to reduce the
prevalence of this ST833 strain. Fortunately, all strains
were phenotypically sensitive to the QAC disinfectant
and we could not amplify the qacA, qacB [15] or qacC
genes [16, 17] which have all been associated with QAC
resistance. Nevertheless, the use of QAC disinfectants is
clearly only a minor part of the measures that are re-
quired to control nosocomial infections.
Venezuelan medical personnel are keenly aware that
carbapenem-resistant K. pneumoniae have become a fre-
quent cause of nosocomial infections in several hospitals
in different Venezuelan cities [8]. We hope that the mo-
lecular epidemiology provided by this study can aid in
tracking the presence and dissemination of the strains
involved, and thereby contribute to the vigilance and
surveillance required to effectively treat them and to re-
duce their presence.
Conclusions
Molecular characterization of 19 carbapenem-resistant
K. pneumoniae strains isolated from pediatric patients in
a large public hospital in Anzoátegui, Venezuela, re-
vealed that all contained the blaKPC-2 and blaVIM-2 genes,
encoding serine and metallo carbapenemases, respect-
ively. MLST analysis showed that all 19 strains belong to
ST833, suggesting an alarming endemic presence of this
strain throughout the hospital’s pediatric service, but
particularly in the neonatal units.
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